I have to say that a large pharmaceutical company would not be in our position. I also feel that the delay has been so long that surely other competitors can't be far behind. Imagine a large company comes out with something similar but just different enough to get around patent law. We have been patient for long enough. Yes shareholders money is just not being respected. Action is needed now before we lose all we have invested.